🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wei Qiao

Jiangnan University

ORCID: 0000-0002-0450-0366

Also affiliated with Chinese Academy of Sciences, Guangzhou Institute of Geochemistry, China University of Geosciences (Beijing), University of Hong Kong - Shenzhen Hospital, China Coal Technology and Engineering Group Corp (China), Institute of Coal Chemistry, Shenzhen Pingle Orthopedic Hospital, University of Chinese Academy of Sciences, University of Hong Kong

Biochemistry, Genetics and Molecular BiologyMedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial”.

Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trial

The Lancet Haematology(2024)10.1016/s2352-3026(24)00250-3
N/A
0.561DataRank · unranked
17 citations

Daniel Nguyen, Elias Jabbour, Jayastu Senapati, Zhihong Zeng, Ghayas C. Issa +14 more

Association between abnormal lipid profile and inflammation and progression of myelodysplastic syndrome to acute leukemia

Experimental Hematology and Oncology(2022)10.1186/s40164-022-00309-7
N/A
0DataRank · unranked
10 citations

Elliana Young, Feng Chun, Suyu Liu, Fengyi Jin, Laila Noor +5 more

Data from Glioma-Associated Cytomegalovirus Mediates Subversion of the Monocyte Lineage to a Tumor Propagating Phenotype

(2023)10.1158/1078-0432.c.6519516
N/A
0DataRank · unranked
0 citations

Jun Wei, Wei Qiao, Mustafa Aziz Hatiboğlu, Ling‐Yuan Kong, Adam Wu +8 more

Outcomes of relapsed or refractory acute myeloid leukemia after frontline hypomethylating agent and venetoclax regimens

Haematologica(2020)10.3324/haematol.2020.252569
N/A
0DataRank · unranked
174 citations

Caitlin R. Rausch, Jörge E. Cortes, Naveen Pemmaraju, Naval Daver, Farhad Ravandi +30 more

Early Obinutuzumab Significantly Increases Bone Marrow Undetectable MRD (10-4 sensitivity) (uMRD4) Rate When Combined with Acalabrutinib and Venetoclax in a Randomized Phase II Trial for Treatment Naïve CLL

Blood(2024)10.1182/blood-2024-211110
N/A
0DataRank · unranked
2 citations

Philip A. Thompson, Jan A. Burger, Musa Yılmaz, Nitin B. Jain, Tapan M. Kadia +23 more

A pilot study of lower doses of ibrutinib: patient body weight does not correlate with plasma ibrutinib levels during therapy

Leukemia & lymphoma/Leukemia and lymphoma(2025)10.1080/10428194.2025.2461672
N/A
0DataRank · unranked
0 citations

Prithviraj Bose, Wei Qiao, Yongying Jiang, Qi Wu, Nichole Cruz +3 more

Data from Glioma-Associated Cytomegalovirus Mediates Subversion of the Monocyte Lineage to a Tumor Propagating Phenotype

(2023)10.1158/1078-0432.c.6519516.v1
N/A
0DataRank · unranked
0 citations

Jun Wei, Wei Qiao, Mustafa Aziz Hatiboğlu, Ling‐Yuan Kong, Adam Wu +8 more